Pharmafile Logo
Pharmafocus logo
Advanced Search

Sanofi looks to close $1 billion deal Flexion

March 24, 2017
Medical Communications, Sales and Marketing Sanofi, flexion therapeutics, osteo

According to reports emerging, Sanofi may be on the verge of closing a deal with Burlington-based biotech, Flexion Therapeutics. The …

News
george_masoura_drugdev_vice_president_business_development_europe_0

DrugDev signs up George Masoura as Vice President of Business Development

March 23, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment

DrugDev has announced the appointment of George Masoura who has joined the company as Vice President, Business Development, Europe to …

Appointment

Advent reportedly backs out of bid for Pfizer’s Brazil plant

March 23, 2017
Sales and Marketing Brazil, Pfizer, generics

It has been reported that Advent International Corp has pulled out of bidding for Pfizer’s stake in Brazilian generics manufacturer, …

News
injection-519388_960_720

Injectable drug market to grow to $625 billion worldwide by 2021

March 23, 2017
Sales and Marketing injectable drugs, injectables

New data released by intelligence firm MarketsandMarkets indicates that the global injectable drug market is set to reach $625 billion …

News
india_flag

Drug prices set to increase on ‘essential medicines’ list in India

March 23, 2017
Sales and Marketing Indian

The annual review of drug prices will see the price of drugs, on the National List of Essential Medicines, increase …

News
shutterstock_146497481

GSK and Regeneron partner with Biobank to analyse 500,000 genetic profiles

March 23, 2017
Research and Development Biobank, GSK, Regeneron

GlaxoSmithKline and Regeneron Pharmaceuticals are to band together in a joint effort with UK Biobank – “the world’s most detailed …

News
shire_image

Shire’s drug picked up from Baxalta given fast track designation

March 23, 2017
Research and Development, Sales and Marketing Shire, rare diseases

Shire has announced that its drug, SHP655, has received a fast track designation based on pre-clinical trials and positive results …

News
fda2outsideweb

FDA approves first Parkinson’s treatment in a decade

March 22, 2017
Research and Development, Sales and Marketing FDA, Parkinson's, Xadago

The FDA has approved Xadago (safinamide) as a supplementary treatment for Parkinson’s in patients currently taking levodopa/carbidopa and who are …

News
shutterstock_292920209

Alternative treatment cures rare blood disease for first time

March 22, 2017
Research and Development congenital dyserythropoietic anaemia

A Chicago man has become the first person ever documented to be cured of congenital dyserythropoietic anaemia (CDA), a rare …

News
gsk_boronia_australia

GSK begins £92 million expansion of UK site

March 22, 2017
Manufacturing and Production, Research and Development GSK, UK

GSK has officially broken ground on the expansion of its site in County Durham. The expanded site will be an …

News
heartbeat

Novartis heart failure drug sinks at Phase 3 trials

March 22, 2017
Research and Development Acute heart failure, Novartis, serelaxin

Novartis’ serelaxin was once thought to be the major hope for its cardiovascular pipeline – analysts projected it to become …

News

Novartis’ psoriasis drug allows some patients to go into remission

March 21, 2017
Research and Development Cosentyx, Novartis, psoriasis

Novartis released data on patient’s reaction to Cosentyx for the treatment of psoriasis, finding that as many as 21% of …

News
shutterstock_291014192

Asia-Pacific NSCLC market to more than double to $6.2bn by 2023

March 21, 2017
Manufacturing and Production, Research and Development, Sales and Marketing BMS, Eli Lilly, MSD, NSCLC, Yervoy, keytruda, opdivo

New research from intelligence provider GBI Research has indicated that the non-small cell lung cancer (NSCLC) market in the Asia-Pacific …

News
lilly_scientists

Lilly’s breast cancer drug meets primary endpoint

March 21, 2017
Manufacturing and Production, Research and Development CDK 4/6 inhibitors, Eli Lilly, abemaciclib

Eli Lilly has announced that its trial of abemaciclib, in combination with fulvestrant, had met its primary endpoint of progression-free …

News

India aims to become “a global innovation hub” for biotechs by 2020

March 21, 2017
Manufacturing and Production, Research and Development India, biotech

The Indian Government has announced its intention to transform the nation into a hub for global biotech activity via its …

News

Biogaran acquires production foothold in Nigeria with Swipha acquisition

March 21, 2017
Manufacturing and Production, Sales and Marketing Biogaran, Swipharma

Biogaran, the French generic manufacturer that is a subsidiary of Servier, has acquired a foothold in Nigeria with a 95% …

News
thumbs_down

Array BioPharma in disarray over withdrawal of NDA

March 20, 2017
Manufacturing and Production, Sales and Marketing Array Biopharma

Array BioPharma has announced that it has pulled its new drug application (NDA) for its drug, binimetinib, for the treatment …

News
shutterstock_311949818

Genentech plans second Phase 3 Alzheimer’s trial following endpoint failures

March 20, 2017
Research and Development, Sales and Marketing Alzheimer's, Genentech, Roche

Genentech, Roche’s biotech group, has announced its plans to conduct a second Phase 3 study for crenezumab, its anti-Abeta antibody …

News
china_wall

China proposes ways to speed up approval for imported drugs

March 20, 2017
Sales and Marketing China, imported drugs

It can currently take up to three or four years for a new drug to reach market in China, slowing …

News
pakistan-895319_960_720

Pakistan’s problem with diabetes – with 7 million diabetics

March 20, 2017
Medical Communications, Sales and Marketing Pakistan, Sanofi, diabetes

Pakistan is facing an increasing problem with people suffering from diabetes. At a recent conference, the 4th International Diabetes Conference, …

News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026